Literature DB >> 10356008

Effect of postal prompts to patients and general practitioners on the quality of primary care after a coronary event (POST): randomised controlled trial.

G Feder1, C Griffiths, S Eldridge, M Spence.   

Abstract

OBJECTIVES: To determine whether postal prompts to patients who have survived an acute coronary event and to their general practitioners improve secondary prevention of coronary heart disease.
DESIGN: Randomised controlled trial.
SETTING: 52 general practices in east London, 44 of which had received facilitation of local guidelines for coronary heart disease. PARTICIPANTS: 328 patients admitted to hospital for myocardial infarction or unstable angina.
INTERVENTIONS: Postal prompts sent 2 weeks and 3 months after discharge from hospital. The prompts contained recommendations for lowering the risk of another coronary event, including changes to lifestyle, drug treatment, and making an appointment to discuss these issues with the general practitioner or practice nurse. MAIN OUTCOME MEASURES: Proportion of patients in whom serum cholesterol concentrations were measured; proportion of patients prescribed beta blockers (6 months after discharge); and proportion of patients prescribed cholesterol lowering drugs (1 year after discharge).
RESULTS: Prescribing of beta bockers (odds ratio 1.7, 95% confidence interval 0.8 to 3.0, P>0.05) and cholesterol lowering drugs (1.7, 0. 8 to 3.4, P>0.05) did not differ between intervention and control groups. A higher proportion of patients in the intervention group (64%) than in the control group (38%) had their serum cholesterol concentrations measured (2.9, 1.5 to 5.5, P<0.001). Secondary outcomes were significantly improved for consultations for coronary heart disease, the recording of risk factors, and advice given. There were no significant differences in patients' self reported changes to lifestyle or to the belief that it is possible to modify the risk of another coronary event.
CONCLUSIONS: Postal prompts to patients who had had acute coronary events and to their general practitioners in a locality where guidelines for coronary heart disease had been disseminated did not improve prescribing of effective drugs for secondary prevention or self reported changes to lifestyle. The prompts did increase consultation rates related to coronary heart disease and the recording of risk factors in the practices. Effective secondary prevention of coronary heart disease requires more than postal prompts and the dissemination of guidelines.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10356008      PMCID: PMC27895          DOI: 10.1136/bmj.318.7197.1522

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  16 in total

1.  Time trend analysis and variations in prescribing lipid lowering drugs in general practice.

Authors:  C Baxter; R Jones; L Corr
Journal:  BMJ       Date:  1998-10-24

2.  Minimisation: the platinum standard for trials?. Randomisation doesn't guarantee similarity of groups; minimisation does.

Authors:  T Treasure; K D MacRae
Journal:  BMJ       Date:  1998-08-08

Review 3.  Implementing guidelines and innovations in general practice: which interventions are effective?

Authors:  M Wensing; T van der Weijden; R Grol
Journal:  Br J Gen Pract       Date:  1998-02       Impact factor: 5.386

4.  Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?

Authors:  D Moher; B Pham; A Jones; D J Cook; A R Jadad; M Moher; P Tugwell; T P Klassen
Journal:  Lancet       Date:  1998-08-22       Impact factor: 79.321

5.  Secondary prevention in coronary heart disease: baseline survey of provision in general practice.

Authors:  N C Campbell; J Thain; H G Deans; L D Ritchie; J M Rawles
Journal:  BMJ       Date:  1998-05-09

6.  Secondary prevention in coronary heart disease: a randomised trial of nurse led clinics in primary care.

Authors:  N C Campbell; L D Ritchie; J Thain; H G Deans; J M Rawles; J L Squair
Journal:  Heart       Date:  1998-11       Impact factor: 5.994

Review 7.  Effectiveness of interventions to enhance physician screening for breast cancer.

Authors:  J Mandelblatt; P A Kanetsky
Journal:  J Fam Pract       Date:  1995-02       Impact factor: 0.493

8.  Methods for comparing event rates in intervention studies when the unit of allocation is a cluster.

Authors:  A Donner; N Klar
Journal:  Am J Epidemiol       Date:  1994-08-01       Impact factor: 4.897

9.  Randomised controlled trial of follow up care in general practice of patients with myocardial infarction and angina: final results of the Southampton heart integrated care project (SHIP). The SHIP Collaborative Group.

Authors:  K Jolly; F Bradley; S Sharp; H Smith; S Thompson; A L Kinmonth; D Mant
Journal:  BMJ       Date:  1999-03-13

10.  Combination antithrombotic therapy in unstable rest angina and non-Q-wave infarction in nonprior aspirin users. Primary end points analysis from the ATACS trial. Antithrombotic Therapy in Acute Coronary Syndromes Research Group.

Authors:  M Cohen; P C Adams; G Parry; J Xiong; D Chamberlain; I Wieczorek; K A Fox; J H Chesebro; J Strain; C Keller
Journal:  Circulation       Date:  1994-01       Impact factor: 29.690

View more
  30 in total

1.  Are postal prompts really ineffective?

Authors:  R Edwards; P Murphy
Journal:  BMJ       Date:  1999-09-11

2.  Management of UTI in general practice: a cost effective analysis. A commentary to facilitate an understanding of economic evaluation.

Authors:  D Kernick
Journal:  Br J Gen Pract       Date:  2000-09       Impact factor: 5.386

3.  Statins and the prevention of coronary heart disease: striking a balance that is desirable, affordable, and achievable.

Authors:  L D Ritchie
Journal:  Br J Gen Pract       Date:  2000-09       Impact factor: 5.386

4.  The primary prevention of coronary heart disease with statins: practice headache or public health?

Authors:  P H Evans
Journal:  Br J Gen Pract       Date:  2000-09       Impact factor: 5.386

5.  Reducing the risk of recurrent coronary heart disease. We know a bit more about what doesn't work.

Authors:  F Bradley; M E Cupples
Journal:  BMJ       Date:  1999-06-05

6.  Recruitment and retention strategies in longitudinal clinical studies with low-income populations.

Authors:  Lisa M Nicholson; Patricia M Schwirian; Elizabeth G Klein; Theresa Skybo; Lisa Murray-Johnson; Ihuoma Eneli; Bethany Boettner; Gina M French; Judith A Groner
Journal:  Contemp Clin Trials       Date:  2011-01-27       Impact factor: 2.226

7.  Secondary prevention of cardiovascular disease: a randomised trial of training in information management, evidence-based medicine, both or neither: the PIER trial.

Authors:  Julia Langham; Helen Tucker; David Sloan; Jane Pettifer; Simon Thom; Harry Hemingway
Journal:  Br J Gen Pract       Date:  2002-10       Impact factor: 5.386

8.  CONSORT statement: extension to cluster randomised trials.

Authors:  Marion K Campbell; Diana R Elbourne; Douglas G Altman
Journal:  BMJ       Date:  2004-03-20

9.  The Enhancing Secondary Prevention in Coronary Artery Disease trial.

Authors:  Finlay A McAlister; Miriam Fradette; Sumit R Majumdar; Randall Williams; Michelle Graham; James McMeekin; William A Ghali; Ross T Tsuyuki; Merril L Knudtson; Jeremy Grimshaw
Journal:  CMAJ       Date:  2009-11-23       Impact factor: 8.262

10.  Efficient Bayesian joint models for group randomized trials with multiple observation times and multiple outcomes.

Authors:  Xinyi Xu; Michael L Pennell; Bo Lu; David M Murray
Journal:  Stat Med       Date:  2012-06-25       Impact factor: 2.373

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.